Blinded Independent Central Review of Progression-Free Survival in Phase III Clinical Trials: Important Design Element or Unnecessary Expense?

Progression-free survival is an important end point in advanced disease settings. Blinded independent central review (BICR) of progression in randomized clinical trials has been advocated to control bias that might result from errors in progression assessments. However, although BICR lessens some po...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Dodd, Lori E., Korn, Edward L., Freidlin, Boris, Jaffe, C. Carl, Rubinstein, Lawrence V., Dancey, Janet, Mooney, Margaret M.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: American Society of Clinical Oncology 2008
Aiheet:
Statistics in Oncology
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC2654812/
https://ncbi.nlm.nih.gov/pubmed/18669467
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2008.16.1711
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia